Ajanta Pharma trades firm in a subdued market as board mulls share buyback

In the past six months, Ajanta Pharma has underperformed the market by gaining 8.9 per cent against 26 per cent rally in S&P BSE Healthcare index

Shares of Ajanta Pharma rose 4 per cent to Rs 1,646 on the BSE on Thursday in an otherwise subdued market after the company announced share buyback plan. Intra-day, the stock had rallied 6 per cent to Rs 1,683 in early morning trade. In comparison, the S&P BSE Sensex was down 0.24 per cent at 39,826 points, at 11:27 am.

Earlier, on October 23, 2020, Ajanta Pharma had informed that the board meeting of the Company scheduled to be held on November 03, 2020 to consider, the unaudited consolidated financial results for the quarter and half year ended September